The scientist’s investigation covers issues in Virology, Epitope, Antibody, Glycoprotein and Virus. His research investigates the connection between Virology and topics such as Immunology that intersect with issues in CD40. The concepts of his Epitope study are interwoven with issues in Protein structure, Molecular biology, Antigenicity and Glycan.
His study focuses on the intersection of Protein structure and fields such as Biophysics with connections in the field of Plasma protein binding. He works mostly in the field of Glycoprotein, limiting it down to topics relating to Protomer and, in certain cases, Isothermal titration calorimetry and Molecular model, as a part of the same area of interest. Per Johan Klasse works mostly in the field of Virus, limiting it down to concerns involving Microbicide and, occasionally, Microbicides for sexually transmitted diseases and Sexual transmission.
His main research concerns Virology, Antibody, Virus, Epitope and Glycoprotein. His Virology research integrates issues from Gp41 and Immunology, Antigen, Immunogenicity. His research integrates issues of Microbicides for sexually transmitted diseases and Microbicide in his study of Immunology.
Per Johan Klasse combines subjects such as Molecular biology and Immune system with his study of Antibody. His study looks at the intersection of Epitope and topics like Glycan with Glycosylation. His study looks at the relationship between Glycoprotein and fields such as Biophysics, as well as how they intersect with chemical problems.
Per Johan Klasse spends much of his time researching Antibody, Glycoprotein, Epitope, Virology and Immunogenicity. His work in Antibody addresses issues such as Virus, which are connected to fields such as Immune system. His Glycoprotein research includes elements of Antigen presentation, Antigenicity, Antigen and Recombinant DNA.
His Antigen study combines topics in areas such as Nanoparticle and Biophysics. His Neutralization study in the realm of Virology connects with subjects such as Hiv 1 transmission. His Neutralization research is multidisciplinary, incorporating elements of Viral entry and Heterologous.
Per Johan Klasse mainly focuses on Antibody, Immunogen, Glycoprotein, Immunogenicity and Neutralizing antibody. His Antibody study incorporates themes from Virus and Antigen. The various areas that Per Johan Klasse examines in his Virus study include Monoclonal antibody and Immunotherapy.
He regularly links together related areas like Virology in his Glycoprotein studies. As a part of the same scientific family, Per Johan Klasse mostly works in the field of Virology, focusing on Epitope and, on occasion, Viral entry. His work deals with themes such as Viral protein, Immunity and Recombinant DNA, which intersect with Immunogenicity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Crystal structure of a soluble cleaved HIV-1 envelope trimer.
Jean-Philippe Julien;Jean-Philippe Julien;Albert Cupo;Devin Sok;Devin Sok;Robyn L. Stanfield;Robyn L. Stanfield.
Science (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders;Rogier W. Sanders;Ronald Derking;Albert Cupo;Jean-Philippe Julien.
PLOS Pathogens (2013)
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
Dmitry Lyumkis;Jean-Philippe Julien;Natalia de Val;Albert Cupo.
Science (2013)
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
Ronald S. Veazey;Robin J. Shattock;Melissa Pope;J. Christian Kirijan.
Nature Medicine (2003)
Phorbol Esters and SDF-1 Induce Rapid Endocytosis and Down Modulation of the Chemokine Receptor CXCR4
Natalie Signoret;Joanne Oldridge;Annegret Pelchen-Matthews;Per J. Klasse.
Journal of Cell Biology (1997)
HIV-1 neutralizing antibodies induced by native-like envelope trimers
Rogier W. Sanders;Rogier W. Sanders;Marit J. Van Gils;Ronald Derking;Devin Sok;Devin Sok.
Science (2015)
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
Jinghe Huang;Byong H. Kang;Marie Pancera;Jeong Hyun Lee.
Nature (2014)
V3: HIV's switch-hitter.
Oliver Hartley;Per Johan Klasse;Quentin J. Sattentau;John P. Moore.
AIDS Research and Human Retroviruses (2005)
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Ronald S. Veazey;Per Johan Klasse;Susan M. Schader;Qinxue Hu.
Nature (2005)
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
Leopold Kong;Jeong Hyun Lee;Katie J Doores;Katie J Doores;Katie J Doores;Charles D Murin.
Nature Structural & Molecular Biology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cornell University
University of Amsterdam
Scripps Research Institute
Scripps Research Institute
Scripps Research Institute
University of Toronto
Duke University
University of Southampton
Uppsala University
Duke University
LG Corporation (South Korea)
Prairie View A&M University
Queen Mary University of London
University of British Columbia
National University of Cuyo
University of Southern California
Federation University Australia
University of New South Wales
Pfizer (United States)
Linköping University
Indian Institute of Technology Kharagpur
Griffith University
University of New Mexico
Cleveland Clinic
University of North Carolina at Chapel Hill
University of South Carolina